Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 1998

View Archived Issues

Ono's new MMP inhibitors

Ebselen: neuroprotective agent in patients with neurological deficits after aneurysmal hemorrhage

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

Spironolactone and Diane 35 may have synergistic effects in hirsutism

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

Efficacy and safety of long-term donepezil in patients with mild to moderate AD

Company Profile: CeNeS

Sumitomo claims compounds for treating reperfusion injury

Xenova: year-end 1997 highlights

Ribi ImmunoChem and Schering-Plough sign distribution agreement for Melacine

EchoGen up for discussion by CPMP and FDA advisory committee

Verapamil analogues reverse MDR in cancer cells

Indazole inhibitors of PDE IV and TNF from Pfizer

Lilly develops selective serotonergic agents

Lilly describes novel compounds for postmenopausal syndrome and related conditions

European patent covers Bayer's new HMG-CoA reductase inhibitors

Faes reveals new antihistamines

AII blocker prevents complications of hypertension in SHR

Taiwan researchers identify lead potassium channel opener selective for bladder

UPSA discloses antiinflammatory/analgesic 1,2-diarylindole derivatives

EntreMed's therapy for insufficient tissue oxygenation heading for clinic

Modified factor VII interrupts the coagulation cascade

Selective iNOS inhibitor improves hepatic circulation and oxygen metabolism in sepsis

Cambridge NeuroScience remains optimistic about the potential of Cerestat

Still hot news: Immunex's Enbrel

Cel-Sci expands North American clinical trial for Multikine

Morphogenesis awarded phase I SBIR grant

Anticancer drug discovery collaboration initiated by Tripos, MDS Panlabs and Cell Pathways

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...